Naproxen: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
Helen (talk | contribs)
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Category: Drugs]][[Category: Non-opioid Analgesic (NSAID)]]
[[Category: Drugs]][[Category: Non-opioid Analgesic (NSAID)]]
'''Naproxen'''(:中文 [[吲哚美辛 ]])is an anti-steroidal anti inflammatory drug, an NSAID. As an NSAID, indomethacin is an analgesic, anti-inflammatory and antipyretic.
'''Naproxen'''(:中文 [[ 萘普生]])is an anti-steroidal anti inflammatory drug, an NSAID. As an NSAID, indomethacin is an analgesic, anti-inflammatory and antipyretic.
Clinical indications for naproxen include:
Clinical indications for naproxen include:
Musculoskeletal and joint disorders
Musculoskeletal and joint disorders
Line 20: Line 20:
|-
|-
|Naproxen Sodium Tablet 275mg
|Naproxen Sodium Tablet 275mg
|
|NAPR01
|P1S1S3
|P1S1S3
|}
|}
Line 47: Line 47:
===Administration in children===
===Administration in children===
{| class="wikitable"
{| class="wikitable"
! juvenile idiopathic arthritis
!Juvenile idiopathic arthritis
(2 years and over)
(2 years and over)
|Oral: 10 mg/kg daily in 2 divided doses.
|-
|-
|Oral: 10 mg/kg daily in 2 divided doses.
!Musculoskeletal disorders
|Aged 1 month to 17 years; Oral: 0.5 to 1 mg/kg twice daily.
|Oral: 5 mg/kg twice daily (maximum of 1 g daily).
|}
|}


==Side Effects==
==Side Effects==
NSAIDs in genera
{| class = "wikitable"
!style="text-align: left"| Common side effects
|heartburn, nausea, dyspepsia, diarrhea, constipation, gastrointestinal ulceration/bleeding, headache, dizziness, rash, salt and fluid retention, and high blood pressure.
|}


===NSAIDs in general===
Naproxen suppositories can cause rectal irritation and occasional bleeding.
Naproxen suppositories can cause rectal irritation and occasional bleeding.


Naproxen should be used with caution in renal impairment, and use is not recommended in patients whose creatinine clearance is less than 20 mL/min.  
Naproxen should be used with caution in renal impairment, and use is not recommended in patients whose creatinine clearance is less than 20 mL/min.  


Common side effects include heartburn, nausea, dyspepsia, diarrhea, constipation, gastrointestinal ulceration/bleeding, headache, dizziness, rash, salt and fluid retention, and high blood pressure.
{| class="wikitable"
 
!Blood
Note: Naproxen poses an intermediate risk of stomach ulcers compared with ibuprofen, which is low-risk, and indomethacin which is high-risk.
|localized spontaneous bleeding, bruising and prolonged bleeding time have been reported
 
|-
Effects on the blood: localized spontaneous bleeding, bruising and prolonged bleeding time have been reported.
!Asthma
|Can be worsen
|-
!Cardiovascular risk
|Chronic ibuprofen use has been found correlated with risk of progression to hypertension and myocardial infarction (heart attack). Both the U.S. Food and Drug Administration (FDA) and The European Medicines Agency (EMA) issues warnings of increased heart attack and stroke risk.
|-
!Skin
|NSAIDs have been associated with the onset of bullous pemphigoid. It can also cause serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, which can be fatal.
|-
!Muscle cramps
|Naproxen may cause muscle cramps in the legs in 3% of people
|-
!Stomach ulcers
|Naproxen poses an intermediate risk of stomach ulcers compared with ibuprofen, which is low-risk, and indomethacin which is high-risk
|}


It also increases the risk of heart attack, stroke, kidney failure and liver failure.
It also increases the risk of heart attack, stroke, kidney failure and liver failure.
NSAID can also worsen asthma.
Naproxen may cause muscle cramps in the legs in 3% of people.
===Cardiovascular risk===
Chronic ibuprofen use has been found correlated with risk of progression to hypertension and myocardial infarction (heart attack). Both the U.S. Food and Drug Administration (FDA) and The European Medicines Agency (EMA) issues warnings of increased heart attack and stroke risk.
===Skin===
NSAIDs has been associated with the onset of bullous pemphigoid. It can also cause serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis which can be fatal.


==Pharmacokinetics==
==Pharmacokinetics==
Naproxen and naproxen sodium are readily absorbed from the gastrointestinal tract. Peak plasma concentrations occur about 1 to 2 hours after ingestion of naproxen sodium and about 2 to 4 hours after ingestion of naproxen.
Naproxen and naproxen sodium are readily absorbed from the gastrointestinal tract. Peak plasma concentrations occur about 1 to 2 hours after ingestion of naproxen sodium and about 2 to 4 hours after ingestion of naproxen.



Latest revision as of 21:39, 13 October 2020

Naproxen(:中文 萘普生)is an anti-steroidal anti inflammatory drug, an NSAID. As an NSAID, indomethacin is an analgesic, anti-inflammatory and antipyretic. Clinical indications for naproxen include: Musculoskeletal and joint disorders

  • rheumatoid arthritis
  • alkylosing spondylitis
  • osteoarthritis
  • gouty arthritis
  • acute painful shoulder bursitis or tendinitis

It is also be used in menstrual pain, headaches, dental pain, postoperative and postpartum pain.

Pronunciation[edit]

Naproxen 250mg[edit]

Drug name[edit]

Generic Name 藥名 HA Code 藥物代碼 Classification藥物分類
Naproxen Sodium Tablet 275mg NAPR01 P1S1S3

Mechanism of Action[edit]

Non-opioid Analgesic (NSAID) Anti-inflammatory agent, Nonselective COX inhibitor, inhibits COX-1 and COX-2 with relative equipotency

Dosage[edit]

Rheumatic disorders Oral : 500 mg to 1 g daily either as a single dose or in 2 divided doses.
Acute gout Oral : initial dose 750 mg followed by 250 mg every 8 hours
Dysmenorrhea Oral : initially 500 mg, followed by 250 mg every 6 to 8 hours, up to a maximum daily dose of 1.25 g on the first day and 1 g thereafter.
Acute musculoskeletal disorders Oral : initially 500 mg, followed by 250 mg every 6 to 8 hours, up to a maximum daily dose of 1.25 g on the first day and 1 g thereafter.

Naproxen has been given rectally in similar doses to those used orally.

Administration in children[edit]

Juvenile idiopathic arthritis

(2 years and over)

Oral: 10 mg/kg daily in 2 divided doses.
Musculoskeletal disorders Oral: 5 mg/kg twice daily (maximum of 1 g daily).

Side Effects[edit]

NSAIDs in genera

Common side effects heartburn, nausea, dyspepsia, diarrhea, constipation, gastrointestinal ulceration/bleeding, headache, dizziness, rash, salt and fluid retention, and high blood pressure.

Naproxen suppositories can cause rectal irritation and occasional bleeding.

Naproxen should be used with caution in renal impairment, and use is not recommended in patients whose creatinine clearance is less than 20 mL/min.

Blood localized spontaneous bleeding, bruising and prolonged bleeding time have been reported
Asthma Can be worsen
Cardiovascular risk Chronic ibuprofen use has been found correlated with risk of progression to hypertension and myocardial infarction (heart attack). Both the U.S. Food and Drug Administration (FDA) and The European Medicines Agency (EMA) issues warnings of increased heart attack and stroke risk.
Skin NSAIDs have been associated with the onset of bullous pemphigoid. It can also cause serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, which can be fatal.
Muscle cramps Naproxen may cause muscle cramps in the legs in 3% of people
Stomach ulcers Naproxen poses an intermediate risk of stomach ulcers compared with ibuprofen, which is low-risk, and indomethacin which is high-risk

It also increases the risk of heart attack, stroke, kidney failure and liver failure.

Pharmacokinetics[edit]

Naproxen and naproxen sodium are readily absorbed from the gastrointestinal tract. Peak plasma concentrations occur about 1 to 2 hours after ingestion of naproxen sodium and about 2 to 4 hours after ingestion of naproxen.

At therapeutic concentrations it is more than 99% bound to plasma proteins.

Diclofenac penetrates synovial fluid; it crosses the placenta and small amounts are distributed into breast milk.

Naproxen has a plasma elimination half-life of about 12 to 17 hours.

It is excreted mainly in the urine (about 95%). Less than 5% of a dose appears in the faeces.

Drug Management[edit]

Efficiency[edit]

Pain and inflammation control

Safety[edit]

Monitor signs of bleeding and bruising, and blood pressure.

Drug Interaction[edit]

Interactions involving NSAIDs include

  • enhancement of the effects of oral anticoagulants
  • increased plasma concentrations of lithium, methotrexate and cardiac glycosides.
  • Risk of nephrotoxicity may be increased if given with ACE inhibitors, ciclosporin, tacrolimus or diuretics
  • Antihypertensive effects of ACEIs, beta blockers and diuretics may be reduced
  • Use of more than one NSAID together (including aspirin) should be avoided because of the increased risk of adverse effects.
  • The risk of gastrointestinal bleeding and ulceration is increased when used with steroids, the SSRIs, the SNRI venlafaxaine, the antiplatelet clopidogrel, bisphosphonates or pentoxifylline.
  • Co-administration of ACE inhibitor can increase risk of kidney problem and increase hypotensive effect.
  • Aspirin.

Precaution[edit]

There has been a report of a patient with Parkinson’s disease whose symptoms had previously been well controlled but who deteriorated when she was given naproxen.

Caution[edit]

  • Allergic reaction,
  • Previous peptic ulcer
  • uncontrolled hypertension,
  • Impaired renal function

Contraindication[edit]

  • Hypersensitivity against diclofenac
  • History of allergic reactions (bronchospasm, rhinitis, urticaria) following the use of other NSAIDs such as aspirin
  • Third-trimester pregnancy
  • Active stomach and/or duodenal ulceration or gastrointestinal bleeding
  • Inflammatory bowel disease such as Crohn’s disease or ulcerative colitis
  • Severe congestive heart failure (NYHA III/IV)
  • Severe liver insufficiency
  • Severe chronic kidney disease (creatinine clearance <30 mi/min)
  • Caution in patients with pre-existing hepatic porphyria, as diclofenac may trigger attacks
  • Caution in patients with severe, active bleeding such as cerebral hemorrhage
  • Caution in patients with fluid retention or heart failure
  • Can lead to onset of new hypertension or worsening of pre-existing hypertension

FAQ[edit]

How should I take the tablet?[edit]

Follow the doctor's prescription Take with food if diclofenac upsets your stomach.

What should I avoid while taking?[edit]

Avoid alcohol consumption.

What happen if I overdose?[edit]

Contact your primary care doctor. If emergency situation, call 999

What happen if I miss a dose?[edit]

Take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.